KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) FCF Margin (2016 - 2025)

Historic FCF Margin for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to 38.34%.

  • Eli Lilly's FCF Margin rose 177000.0% to 38.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.6%, marking a year-over-year increase of 121800.0%. This contributed to the annual value of 8.35% for FY2024, which is 60300.0% up from last year.
  • Eli Lilly's FCF Margin amounted to 38.34% in Q3 2025, which was up 177000.0% from 8.93% recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's FCF Margin peaked at 38.34% during Q3 2025, and registered a low of 14.78% during Q4 2023.
  • Its 5-year average for FCF Margin is 13.51%, with a median of 15.26% in 2023.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by -306900bps in 2023, then skyrocketed by 220100bps in 2024.
  • Over the past 5 years, Eli Lilly's FCF Margin (Quarter) stood at 24.63% in 2021, then plummeted by -35bps to 15.91% in 2022, then crashed by -193bps to 14.78% in 2023, then soared by 149bps to 7.23% in 2024, then surged by 431bps to 38.34% in 2025.
  • Its FCF Margin was 38.34% in Q3 2025, compared to 8.93% in Q2 2025 and 1.23% in Q1 2025.